Galenica
Pharmaceuticals
GALE.SW
CHF 72 (0.82)%
Share price
$ 3.9 bn
Market Cap
$ 4.6 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Galenica aims to reduce all Scopes by 25% by 2025 from a base year 2021
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
Galenica reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 7.7 Kt (+1.4/+22% y-o-y). Carbon intensity also grew to 1.8 t (+0.1/+5.9% y-o-y).
Galenica's Scope 3 emissions grew to 4.4 Kt (
The company is committed to reducing all Scopes by 25% by 2025 from a base year 2021, which translates into the estimated reduction of -0.76 Kt per annum over the period of FY2022 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.